 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: KESIMPTA (ofatumumab) |
|
***************************************************** |
|
#Post#: 5021-------------------------------------------------- |
|
(Abst.) 6-year safety and efficacy outcomes w/first-line ofatumu |
|
mab in recently diagnosed pts. w/relapsing MS |
|
By: agate Date: December 13, 2025, 1:13 am |
|
--------------------------------------------------------- |
|
From PubMed (December 12, 2025)--"Six-year safety and efficacy |
|
outcomes with first-line ofatumumab in recently diagnosed |
|
treatment-naive patients with relapsing multiple sclerosis": |
|
https://pubmed.ncbi.nlm.nih.gov/41380509/ |
|
***************************************************** |
